2023 is a year of diversified development in the field of disease prevention in the post-epidemic era, and in this year, Yuanta Healthcare's subordinate brand Hippo Miao Miao actively carries the social mission, creates a benchmark for health services, and realizes the multi-dimensional leapfrog and development of the brand.
Since the 18th National Congress of the Communist Party of China, the construction of a healthy China has been elevated to a national strategy, and a series of reform measures have been formulated and introduced to promote the rapid development of health care and significantly improve the health level of the people. As a consumer medical service brand, Hippo Miaomiao not only meets the increasingly diverse consumer medical appointment needs of the people with high quality, but also helps the "public health work" by breaking the information barrier through the publicity and education work of its entire Internet platform.
Mr. Li, the founder of Yuanta Healthcare, said in an interview that Yuanta Healthcare's mission is to "make disease prevention more efficient", and in the context of the post-pandemic, Internet and stability era, medical service companies need to undertake the social mission of publicity, education, and breaking the information cocoon.
Adhering to the concept of empowering medical resources with the "intelligence" of products, Hippo Miaomiao has precipitated 70,000 high-net-worth users in 2023 with its strong business characteristics and diversified cooperation model. 
Mr. Li said that Hippo Miaomiao, as an emerging brand, has achieved this achievement thanks to the standardized operation under the strategic planning of the enterprise, the joint efforts under the endorsement of cooperative enterprise resources, and the risk aversion after the development of predecessors in the industry; In addition, the Group's terrestrial outpatient and Internet hospital brands have also added new momentum to its medical service segment.
In 2024, Hippo Miaomiao will continue to promote the perfect implementation of more medical service products with strong needs, and lead the development of the industry with enterprise business innovation.